These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 36495504)
1. Expression profiles of miR-129 and miR-29a-5p in vascular calcification of patients with end-stage renal disease and the underlying correlation. Sheng Y; Ma X; Wang N; Yang X; Zhang H; Xu H; Sun F Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):148-152. PubMed ID: 36495504 [TBL] [Abstract][Full Text] [Related]
2. Expression of mir-29a-5p, sclerostin and fetuin-A in patients with chronic kidney disease and their correlation with vascular calcification. Ma X; Sheng Y; Yang X; Wang N; Zhang H; Xu H; Sun F Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):70-74. PubMed ID: 36495516 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of miR-29a-5p involvement in osteogenic phenotype transformation and cellular regulation of vascular smooth muscle and thus influencing calcification in VSMCs in chronic kidney disease. Deng H; Xu H; Luo Y Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):123-128. PubMed ID: 36495508 [TBL] [Abstract][Full Text] [Related]
4. [Significance of microRNA 216a, 324-5p and 29a expression in peripheral blood in patients with acute pancreatitis and their correlation with liver injury]. Han YY; Wang CY; Yang L; Zhao GY; Liu HL; Li JZ; Chen PL; Cui K Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(27):2126-2131. PubMed ID: 32689754 [No Abstract] [Full Text] [Related]
5. Clinical Significance of miR-21-5p in Predicting Occurrence and Progression of Uremic Vascular Calcification in Patients with End-Stage Renal Disease. Wu R; Zhou S; Liu M; An H; Wang Z; Liu T Yonsei Med J; 2022 Mar; 63(3):252-258. PubMed ID: 35184427 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-211-5p as a Biomarker in Early Detection of Uremic Vascular Calcification among Patients with End-Stage Renal Disease. Liu X; Wu P; Zhang H; Li L; Xiao H Arch Esp Urol; 2022 Oct; 75(8):714-719. PubMed ID: 36330573 [TBL] [Abstract][Full Text] [Related]
7. PTH-induced EndMT via miR-29a-5p/GSAP/Notch1 pathway contributed to valvular calcification in rats with CKD. Wang L; Tang R; Zhang Y; Chen S; Guo Y; Wang X; Liu Z; Liu H; Zhang X; Liu BC Cell Prolif; 2021 Jun; 54(6):e13018. PubMed ID: 33945189 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. Du Y; Gao C; Liu Z; Wang L; Liu B; He F; Zhang T; Wang Y; Wang X; Xu M; Luo GZ; Zhu Y; Xu Q; Wang X; Kong W Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2580-8. PubMed ID: 22995515 [TBL] [Abstract][Full Text] [Related]
9. Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis. Tavano F; Fontana A; Mazza T; Gioffreda D; Biagini T; Palumbo O; Carella M; Andriulli A Front Oncol; 2020; 10():1567. PubMed ID: 33072549 [TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis]. Wu K; Wang L; Fu G; Zheng Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354 [TBL] [Abstract][Full Text] [Related]
11. MiR-133a is a potential target for arterial calcification in patients with end-stage renal disease. Li S; Zhi F; Hu M; Xue X; Mo Y Int Urol Nephrol; 2022 Jan; 54(1):217-224. PubMed ID: 34115259 [TBL] [Abstract][Full Text] [Related]
12. 17 Zhang ML; Chen H; Yang Z; Zhang MN; Wang X; Zhao K; Li X; Xiu N; Tong F; Wang YX Mediators Inflamm; 2021; 2021():9921897. PubMed ID: 34220338 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-17-5p Promotes Vascular Calcification by Targeting ANKH. Shi C; Tan J; Lu J; Huang J; Li X; Xu J; Wang X Curr Neurovasc Res; 2022; 19(1):108-116. PubMed ID: 35297350 [TBL] [Abstract][Full Text] [Related]
14. Analysis of profibrogenic microRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1-4 patients and their relationship with proteinuria and kidney function. Donderski R; Szczepanek J; Naruszewicz N; Naruszewicz R; Tretyn A; Skoczylas-Makowska N; Tyloch J; Odrowąż-Sypniewska G; Manitius J Int Urol Nephrol; 2022 Apr; 54(4):937-947. PubMed ID: 34312814 [TBL] [Abstract][Full Text] [Related]
15. miR-29a-5p/STAT3 Positive Feedback Loop Regulates TETs in Colitis-Associated Colorectal Cancer. Wang A; Deng S; Chen X; Yu C; Du Q; Wu Y; Chen G; Hu L; Hu C; Li Y Inflamm Bowel Dis; 2020 Mar; 26(4):524-533. PubMed ID: 31750910 [TBL] [Abstract][Full Text] [Related]
16. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer. He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491 [TBL] [Abstract][Full Text] [Related]
17. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2. Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640 [TBL] [Abstract][Full Text] [Related]
18. miR-29a-5p Inhibits Prenatal Hair Placode Formation Through Targeting EDAR by ceRNA Regulatory Network. Jiang Y; Liu H; Zou Q; Li S; Ding X Front Cell Dev Biol; 2022; 10():902026. PubMed ID: 35646897 [TBL] [Abstract][Full Text] [Related]
19. miR-29a-3p/T-bet Regulatory Circuit Is Altered in T Cells of Patients With Hashimoto's Thyroiditis. Tokić S; Štefanić M; Glavaš-Obrovac L; Kishore A; Navratilova Z; Petrek M Front Endocrinol (Lausanne); 2018; 9():264. PubMed ID: 29881372 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of plasma microRNA-30b-5p combined with extravascular lung water index in patients with acute respiratory distress syndrome]. Li C; Tan M; Wang S; Cai X; Li X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):570-574. PubMed ID: 32576349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]